Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: The James Cancer Center ×

The James Cancer Center

This institution is selected. Its supporting articles are shown below.

The James Cancer Center1

Articles mentioning The James Cancer Center

1 articles · page 1 of 1

1345 Initial phase 1a/1b results of STK-012, an α/β IL-2 receptor biased partial agonist, with pembrolizumab, pemetrexed, and carboplatin in 1L PD-L1 negative non-squamous NSCLC

jitc · abstract · 2025-11-07 · 1 matching annotations

78.4%

Dana Farber Cancer Institute Memorial Sloan Kettering Cancer Center Yale Cancer Center The James Cancer Center Georgetown Lombardi Cancer Center Hoag Family Cancer Institute NYU Grossman School of Medicine STK-012 1L NSQ NSCLC pembrolizumab

…CT The James Cancer Center, Ohio State University, Columbus, OH Dana Farber Cancer Institute, Boston, MA, Columbia University Irving Medical Center, New Yor…

Browse institutions

The James Cancer Center

Articles mentioning The James Cancer Center

1345 Initial phase 1a/1b results of STK-012, an α/β IL-2 receptor biased partial agonist, with pembrolizumab, pemetrexed, and carboplatin in 1L PD-L1 negative non-squamous NSCLC